Detector Technology, a supplier of products and manufacturing services to analytical and laboratory equipment manufacturers and a portfolio company of Ampersand Capital Partners, has acquired Scientific Instrument Services.
Scientific Instrument Services (SIS) is a manufacturer of mass spectrometry filaments and ion optic assemblies. The company also distributes a line of laboratory supplies for mass spectrometers, gas chromatographs and related scientific laboratory equipment. SIS is headquartered halfway between Philadelphia and New York in Ringoes, NJ (www.sisweb.com).
“The acquisition of SIS is our first step towards building a leading contract manufacturer of lab products,” said Jay Ray, President and CEO of DeTech. “The acquisition allows us to strengthen our initial strategic vision of being the market leader in mass spectrometry contract manufacturing. DeTech is focused on continuing to expand its liquid handling and automation capabilities, and our growth will provide our customers innovative product solutions, enhanced support and operational efficiencies.”
Detector Technology (DeTech) is a contract manufacturer of products and systems for OEM and equipment manufacturers. The company specializes in channel electron multipliers that are used in mass spectrometry and gas analysis; glass extrusion and fabrication; and motion control products. DeTech was founded in 1983 and has a 30,000 sq. ft. manufacturing and headquarters facility in Palmer, MA (www.detechinc.com).
The two merged companies’ manufacturing and engineering resources will expand its customized product development and production capabilities for its combined global OEM clients. “The benefits that our OEM partners will realize from this business combination are meaningful given the complementary aspects of our product development and manufacturing capabilities,” said Chris Baker, President of SIS. “We are very excited to be part of the DeTech market leadership vision, world-class manufacturing and best-in-class products.”
DeTech will remain headquartered in Palmer while maintaining the presence of manufacturing and support from the SIS facilities in New Jersey and Pennsylvania.
Ampersand makes majority or minority equity investments of $10 million to $50 million in healthcare related companies that have from $10 million to $100 million of revenue. Ampersand is typically the first institutional investor in founder-owned businesses. Sectors of specific interest within healthcare include laboratory services; laboratory products; contract manufacturing; pharmaceutical services; and specialty pharmaceuticals. Ampersand is based in the Boston suburb of Wellesley, MA (www.ampersandcapital.com).
© 2018 Private Equity Professional | February 21, 2018
